Research at OnkPat
OnkPat consists of more than 30 research groups
Prognostic importance of PDL-1 in breast cancer
Theodoros Foukakis with colleagues in Belgium and OnkPat has compiled an analysis of the immuno-checkpoint protein PDL-1 (a target for immunotherapy) and shown that it can predict the prognosis for breast cancer. The results have been published in Clinical Cancer Research.
High impact publication in Lancet Oncology
Hanna Eriksson and Johan Hansson with colleagues in the Netherlands have published an article in Lancet Oncology where they show that it is better to give neoadjuvant immunotherapy to cancer patients before the surgeon removes a tumor instead of afterwards.
Two assistant professorships sponsored by the Swedish Childhood Cancer Fund
Monika Ehnman and Nina Gustafsson Sheppard were granted funding for four years assistant professorships from the Swedish Childhood Cancer Fund.
Grants from Dr Åke Olsson Foundation for Hematological Research 2019
This year four researchers from the Department of Oncology-Pathology will share a grant of 2 000 000 SEK: Isabelle Magalhaes, Jeanette Lundin, Nina Gustafsson Sheppard and Mohammad Hojjat Farsangi.